0001209191-20-062345.txt : 20201208
0001209191-20-062345.hdr.sgml : 20201208
20201208182126
ACCESSION NUMBER: 0001209191-20-062345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201205
FILED AS OF DATE: 20201208
DATE AS OF CHANGE: 20201208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YOUNG JAMES F
CENTRAL INDEX KEY: 0001219864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 201376385
MAIL ADDRESS:
STREET 1: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-05
0
0001000694
NOVAVAX INC
NVAX
0001219864
YOUNG JAMES F
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Restricted Stock Units
2020-12-05
4
A
0
20000
0.00
A
Common Stock
20000
20000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
This grant was made under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, in connection with the appointment of the Reporting Person as Chair of a newly established standing Research and Development Committee of the Board of Directors of the Company. Fifty percent (50%) of the RSUs subject to this grant will vest on January 1, 2021, and the remaining fifty percent (50%) of the RSUs subject to this grant will vest on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through the vesting date.
/s/ John A. Herrmann III, Attorney-in-Fact
2020-12-08